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Sustarsic et al. reveal that synthesis of the
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activation by cold temperature. This
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only shapes adipose mitochondrial
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sensitivity and metabolic flexibility.
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Activation of energy expenditure in thermogenic fat
is a promising strategy to improve metabolic health,
yet the dynamic processes that evoke this response
are poorly understood. Here we show that synthesis
of the mitochondrial phospholipid cardiolipin is
indispensable for stimulating and sustaining ther-
mogenic fat function. Cardiolipin biosynthesis is
robustly induced in brown and beige adipose upon
cold exposure. Mimicking this response through
overexpression of cardiolipin synthase (Crls1) en-
hances energy consumption in mouse and human
adipocytes. Crls1 deficiency in thermogenic adipo-
cytes diminishes inducible mitochondrial uncoupling
and elicits a nuclear transcriptional response through
endoplasmic reticulum stress-mediated retrograde
communication. Cardiolipin depletion in brown and
beige fat abolishes adipose thermogenesis and
glucose uptake, which renders animals insulin resis-
tant. We further identify a rare human CRLS1 variantCell Metabolism 28, 159–174
This is an open access article undassociated with insulin resistance and show that ad-
ipose CRLS1 levels positively correlate with insulin
sensitivity. Thus, adipose cardiolipin has a powerful
impact on organismal energy homeostasis through
thermogenic fat bioenergetics.
INTRODUCTION
Brown adipose tissue (BAT) is a specialized organ that converts
carbohydrate and lipid substrates to thermal energy to defend
body temperature in response to cold environments (Cannon
and Nedergaard, 2004). This core function of BAT depends on
robust electron transport activity that is fueled by a capacity for
glucose and lipid consumption proportionally greater than any
other tissue (Bartelt et al., 2011; Labbe et al., 2015). Another
type of cell, known as a ‘‘beige’’ or ‘‘brite’’ adipocyte, can be
recruited to become thermogenically active through a process
called ‘‘browning’’ (Peirce et al., 2014; Petrovic et al., 2010; Sha-
balina et al., 2013;Wuet al., 2012). Inmice, thesecells are located
primarily in subcutaneous white adipose tissue (scWAT) and
possess thermogenic capacity through both UCP1-dependent, July 3, 2018 ª 2018 The Author(s). Published by Elsevier Inc. 159
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
(Shabalina et al., 2013) and -independent means (Kazak et al.,
2015). In rodents, both brown and beige adipocytes (also known
as thermogenic adipocytes) are protective againstmetabolic dis-
ease (Cohen et al., 2014; Feldmann et al., 2009). The presence of
thermogenic adipocytes in adult humans (Cypess et al., 2009;
van Marken Lichtenbelt et al., 2009; M€uller et al., 2016; Saito
et al., 2009; Virtanen et al., 2009) has opened up the possibility
to exploit these fat cells to treat obesity and diabetes (Betz
and Enerb€ack, 2015; Harms and Seale, 2013; Kusminski et al.,
2016; Lee et al., 2013; Sidossis and Kajimura, 2015).
Exposure to cold temperature is the most robust way to elicit
the adipose tissue thermogenic response. Previous analyses
of single bouts of cold exposure have yielded valuable insights
into cold-induced transcriptional programming (Hao et al.,
2015; Marcher et al., 2015), lipid composition (Marcher et al.,
2015), UCP1-independent thermogenic mechanisms (Kazak
et al., 2015), and comparisons between brown and white adi-
pose responses (Rosell et al., 2014; Shore et al., 2013). However,
the ability of adipose tissue to expend energy is a dynamic pro-
cess that continues to increase with prolonged cold exposure,
only reaching maximal capacity after several weeks (Cannon
and Nedergaard, 2004). This temporal progression is demon-
strated by a brown fat mitochondrial proteomics study that
revealed differential changes in respiratory chain complexes
between two time points of cold exposure (Forner et al., 2009).
Here we set out to temporally map the global BAT proteome
throughout cold adaptation in order to identify key regulators
of thermogenesis. We found that lipid metabolism processes
were the most dynamic and robustly induced pathways in
response to cold. Therefore, we surveyed the cold-regulated
lipid landscapes of brown and beige adipose using targeted lip-
idomics. We found that cardiolipins (CLs) were the lipids most
significantly induced by cold in both thermogenic fat depots.
CLs are unique phospholipids that are synthesized and predom-
inantly located in the mitochondrial inner membrane. CLs are
ascribed numerous roles in mitochondrial biology, including res-
piratory chain supercomplex formation, cytochrome c seques-
tration, OPA1-mediated fusion, and mitochondrial carrier activa-
tion (Houtkooper and Vaz, 2008; Paradies et al., 2014; Shi, 2010).
Originally discovered in bovine heart, these lipids have been
almost exclusively studied in cardiac and skeletal muscle, brain,
and liver (Houtkooper and Vaz, 2008; Shi, 2010). Earlier studies
have observed increases in BAT CLs with cold exposure (Ogawa
et al., 1987; Ricquier et al., 1978); however, the physiological role
of CL in thermogenic fat remains unknown. Here, we demon-
strate that the mitochondrial lipid CL shapes brown and beige
fat bioenergetics to profoundly affect organismal metabolic
fitness and glucose homeostasis.
RESULTS
Lipid Metabolism Pathways Dominate the Thermogenic
Fat Proteome during Cold Adaptation
We first set out to obtain an unbiased, temporal view of the cold
adaptive protein landscape in thermogenic adipose tissue. We
performed semiquantitative, tandem mass tag-mass spectrom-
etry on interscapular BAT (iBAT) from mice housed at thermo-
neutrality (i.e., lowest thermogenesis) or subjected to 5C cold
challenges ranging from acute (i.e., 8 hr) to full cold adaptation160 Cell Metabolism 28, 159–174, July 3, 2018(i.e., 3 weeks). A total of 5,552 detected proteins were common
between the two multiplexed datasets. Of these, 1,400 proteins
were significantly changed during cold adaptation (Figures 1A
and S1A; Data S1). Knownmarkers of BAT activation were highly
induced in cold exposed mice (Figure S1B).
To identify time-dependent changes in metabolite pathways,
we examined the temporal enrichment of proteins involved in
amino acid, nucleotide, carbohydrate, and lipid metabolism (Fig-
ure 1B). Both carbohydrate and lipid metabolism pathways were
notably enriched after 1 day of cold and sustained throughout
cold adaptation. However, the enrichment of lipid metabolism
proteins far eclipsed that of proteins involved in all other metab-
olite pathways from 3 days to 3 weeks of cold exposure (Fig-
ure 1B). This shift marked a distinct transition in the cold adaptive
proteome. To uncover themost critical processes contributing to
this transition, we focused our analysis on proteins significantly
upregulated by 3 days, 1 week, and 3 weeks of cold (Figure 1C,
dashed blue box). Strikingly, this sub-group represented the
largest common overlap between any time points, suggesting
a strong core signature. Consistent with our earlier findings on
metabolite pathways (Figure 1B), this group of 103 cold-induced
proteins was the most enriched for lipid metabolism processes,
with phospholipid metabolism, triglyceride biosynthesis, and
glycerophospholipid biosynthesis as the top three pathways
represented (Figure 1D). Together, these data indicate that
the iBAT proteome undergoes a major transition between
acute and chronic cold exposure that is dominated by lipid
metabolism.
Environmental Activation of Brown and Beige Fat
Robustly Induces Cardiolipin Synthesis
The profound impact of cold exposure on iBAT lipid-metabo-
lizing enzymes (Figures 1B and 1D) prompted us to interrogate
the brown fat lipidome. Using targeted, quantitative mass spec-
trometry, iBAT lipidomic profiles were obtained from mice
housed at thermoneutrality or subjected to a 5C cold challenge
for 3 hr, 3 days, or 3 weeks. Of the 287 lipids surveyed, 250 were
significantly altered in iBAT by cold exposure (Figure S2A; Data
S2). Themost cold-induced lipid species in brown fat weremem-
bers of the cardiolipin (CL) phospholipid family (Figure 2A). Our
findings place previously observed cold induction of cardiolipins
(Ogawa et al., 1987; Ricquier et al., 1978) in a more global
context of the brown fat lipidome. We additionally obtained lipi-
domic profiles from scWAT depots at thermoneutrality and after
3 weeks of cold to pinpoint critical lipids conserved between
brown and beige depots. Thirty-two lipid species were changed
in scWAT following cold adaptation (Figure S2B; Data S2) and,
as in iBAT, we found themost cold-induced lipid species in beige
fat were also CLs (Figure 2B).
CLs are synthesized in the mitochondrial inner membrane by
coupling cytidine diphosphate-diacylglycerol (CDP-DAG) with
phosphatidylglycerol (PG) (Figure 2C). Notably, PGs were also
among the highest induced lipids in thermogenic fat (Figures
2A, 2B, S2C, and S2D). Newly synthesized CL is characterized
by shorter, more saturated acyl chains, which can be remodeled
by phospholipases, and acyltransferases through monolysocar-
diolipin (monolysoCL) intermediates to generate a diverse pool
of CLs. This diversity is thought to enable CLs to influence a
wide array of mitochondrial functions (Houtkooper and Vaz,
Figure 1. Lipid Metabolism Pathways Are the Key Signature of the Brown Fat Cold Adaptive Proteome
(A) Heatmap of Z score transformed expression of 1,400 significantly changed proteins in BAT during cold adaptation (n = 4 for 29C and 5C 3 weeks, n = 3 for
other groups; ANOVA adjusted p value <0.05).
(B) Temporal pattern of amino acid, nucleotide, carbohydrate, and lipidmetabolismReactome pathways during cold adaptation. The size of the bubbles indicates
the number of pathway proteins upregulated by cold (t test and fold change >1.5).
(C) Venn diagram of proteins induced by cold >1.5-fold.
(D) Pathway enrichment of common proteins between 3 days, 1 week, and 3 weeks cold that were induced >1.5-fold. Dashed lines indicate adjusted p value
<0.05. ETC, electron transport chain; PC, phosphatidylcholine; PE, phosphatidylethanolamine; TCA, tricarboxylic acid.
See also Figure S1.2008; Paradies et al., 2014; Shi, 2010). Among the 15 targetedCL
and monolysoCL species measured, we found six were signifi-
cantly upregulated by cold in iBAT and four in scWAT (Figures
2D and S2E). The most cold-induced CL species in brown and
beige adipose were largely nascent or within the early stages
of remodeling. Together, these data show that increased CL syn-
thesis is a conserved lipid signature of activated thermogenic
brown and beige fat.Cardiolipin Synthase 1 Enhances Inducible
Mitochondrial Uncoupling in Thermogenic Adipocytes
To identify the enzyme or enzymes responsible for the striking
elevation of CLs in activated brown and beige fat, we examined
the cold regulation of CL-metabolizing enzymes in iBAT (Fig-
ure 2E). CL synthase 1 (CRLS1) was the most robustly induced
CL enzyme throughout cold adaptation. Notably, the pattern of
CRLS1 induction closely paralleled that of iBAT CL levelsCell Metabolism 28, 159–174, July 3, 2018 161
Figure 2. Cardiolipins Are Robustly Increased in Activated Brown and Beige Fat
(A) Ten most cold-induced lipids from lipidomic analysis of iBAT from mice housed at thermoneutrality or exposed to 5C cold for 3 hr, 3 days, or 3 weeks (fold
change relative to thermoneutral, 29C = 1; n = 4 per group, one-way ANOVA).
(B) Top ten cold-induced lipids from lipidomic analysis of scWAT from mice housed at thermoneutrality or exposed to 5C cold for 3 weeks (fold change of
absolute quantities normalized to protein content, 29C = 1; n = 4 per group, t test). CL, cardiolipin; PG, phosphatidylglycerol; CAR, acyl carnitine.
(C) Schematic of cardiolipin synthesis and remodeling; CDP-DAG, cytidine diphosphate diacylglycerol; CMP, cytidine monophosphate.
(D) Heatmaps of log2 (fold change cold treated/thermoneutrality) for CL species in iBAT and scWAT (n = 4 per group, one-way ANOVAs for iBAT and t tests for
scWAT; gray, not detected).
(E) Relative iBAT protein levels of cardiolipin de novo synthesis and remodeling pathway enzymes from proteomic analysis presented in Figure 1A (n = 4 for 29C
and 5C 3 weeks, n = 3 for other groups; one-way ANOVA).
(F) Tissue distribution of Crls1 from mice housed at thermoneutrality or cold exposed for 3 weeks (n = 6 per group; t test).
(legend continued on next page)
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(Figure 2A), both of which were significantly increased beginning
at 3 days of cold exposure. An examination of gene expression
across 20 mouse tissues revealed that Crls1 was highest en-
riched in iBAT and was further increased by cold exposure in
both iBAT and scWAT (Figure 2F). The Genotype-Tissue Expres-
sion (GTEx) database showed that CRLS1 is also highest ex-
pressed in human adipose. Consistent with our mouse data,
CRLS1 expression wasmore abundant in human supraclavicular
brown fat versus subcutaneous fat and correlated with UCP1
levels (Figures 2G and 2H). Taken together, these data support
a role for CRLS1 and CL biosynthesis in mouse and human
brown fat.
To assess the functional consequences of Crls1 cold induc-
tion, we transiently overexpressedCrls1 in primarymouse brown
and subcutaneous adipocytes. Ectopic Crls1 expression in both
cell types significantly enhanced norepinephrine (NE)-induced
uncoupled respiration, a hallmark of thermogenic metabolism
(Cannon and Nedergaard, 2004) (Figures 3A and 3B).Crls1 over-
expression in brown adipocytes also led to increased Ucp1
mRNA levels (Figure 3A). Conversely, small interfering RNA
(siRNA)-mediated Crls1 knockdown in brown and white thermo-
genic adipocytes significantly reduced NE-induced uncoupled
respiration (Figures 3C, 3D, and S3A–S3F) and decreased
Ucp1 expression in brown fat cells (Figure S3F). Surprisingly,
acute Crls1 deficiency had little impact on other parameters of
mitochondrial respiration, including basal, coupled, andmaximal
oxygen consumption (Figures 3C and 3D), which could be due to
the long half-life of CL.
Cardiolipin Is Essential for Acute and Adaptive Features
of the Adipose Thermogenic Program
To investigate the role of adipose CL in vivo, we generated a
conditional knockout mouse model targeting exon 4 of the
Crls1 gene (Crls1f/f). Tamoxifen (TAM)-induced deletion of
Crls1 exon 4 in primary brown adipocytes reduced CL synthesis
and decreased inducible uncoupled respiration, mirroring our
siRNA results (Figures 3E, 3F, and S3H). The acute nature of
Crls1 knockdown in our cell models paired with the slow turnover
of CLs could account for the modest inhibition of uncoupled
respiration observed in vitro. To generate constitutive adipose-
specific Crls1 knockout (AdCKO) mice (Figure 4A), we crossed
Crls1f/f mice with animals expressing Cre recombinase under
the control of the adiponectin promoter (Eguchi et al., 2011).
Crls1 mRNA and protein were nearly abolished across adipose
depots in AdCKO mice (Figures 4A and S4A). Mass spectrom-
etry-based lipidomics of AdCKO iBAT revealed a virtual ablation
of all CL species (Figure 4B), resulting in AdCKO iBAT that was
distinctly pale compared with controls (Figure 4B, inset).
The AdCKO iBAT expression profile of genes linked to ther-
mogenesis, adipogenesis, and mitochondrial respiration more
closely resembled that of white fat than brown (Figures S4B
and S4C). Brown adipose from AdCKO mice also had reduced
mitochondrial mass (Figures S4D), disrupted cristae structure(G and H) (G)CRLS1 levels in human subcutaneous fat (n = 8) and brown fat with h
and (H) correlation with UCP1 in scWAT (n = 8; white), low-UCP1 BAT (n = 8, UCP
Pearson R2 and p value shown). Data are presented as means ±SEM. *p < 0.05;
See also Figure S2.(Figure 4C), altered respiratory chain complex and supercom-
plex formation (Figure S4E), and reduced GDP-inhibitable
(UCP1-linked) respiration in isolated mitochondria (Figure S4F).
The mitochondrial dysfunction in AdCKO iBAT resulted in dis-
torted cellular and lipid droplet morphology (Figures 4D, 4E,
and S5A–S5D; Videos S1 and S2). Interestingly, loss of Crls1
was not as detrimental to white adipose depots (Figures S4B,
S4C, and S5C). Although mtDNA content was markedly
decreased in AdCKO brown fat, mtDNA levels in epididymal
white adipose tissue (eWAT) were unchanged (Figure S5D).
We next assessed the role of adipose CL in body temperature
defense during acute cold exposure. Cold tolerance was sub-
stantially reduced in AdCKO mice (Figure 4F). To specifically
interrogate thermogenic fat activity, NE was administered to
anesthetized mice at thermoneutrality. Whereas NE robustly
induced oxygen consumption and heat production in controls,
these effects were largely abolished in AdCKO mice (Figures
4G–4I). These effects were more dramatic than those observed
in our cellular loss-of-function studies, likely due to the more
complete loss of CLs in our in vivo model. In addition, cold
exposure did not induce Ucp1 transcription in iBAT or scWAT
of AdCKO mice (Figures 4J and 4K).
Another characteristic feature of mouse and human thermo-
genic fat is a profound ability to consume glucose from the blood
in response to cold or b3-adrenergic stimulation (Cannon andNe-
dergaard, 2004;Cypesset al., 2009; vanMarkenLichtenbelt et al.,
2009; Saito et al., 2009; Virtanen et al., 2009). To test the impact of
CLonglucoseuptake in vivo,wemeasured the inducibleaccumu-
lation of 18F-fluorodeoxyglucose (FDG) into iBAT by positron
emission tomography/computed tomography (PET/CT). Animals
were injectedwith the b3 agonist CL-316,243 to specifically stim-
ulate glucose uptake into thermogenic fat. Loss of adipose CL
reduced brown fat glucose uptake compared with controls (Fig-
ures 4L and 4M; Videos S3 and S4). These collective findings
show that CL integrally shapes both acute and adaptive thermo-
genic responses and inducible glucose uptake in fat.
Mitochondrial CL Deficiency Suppresses
Nuclear-Encoded Genes through the Endoplasmic
Reticulum Stress Response Factor CHOP-10
CL is well established as a direct modulator of mitochondrial
structure and bioenergetic capacity (Houtkooper and Vaz,
2008; Paradies et al., 2014). However, our observations
revealing Crls1-dependent regulation of Ucp1 transcription in
both cells and tissue (Figures 3A, 3B, S3F, and S4B) suggest
an additional role for CLs in retrograde communication from
the mitochondria to the nucleus. This phenomenon is unlikely
due to general mitochondrial dysfunction as other models in
which adipose mitochondria are severely disrupted do not result
in altered Ucp1 expression (Ryu et al., 2013; Vernochet et al.,
2014). Comparison of AdCKO and control iBAT transcriptomes
revealed that CL depletion globally decreased oxidative phos-
phorylation and other mitochondrial gene programs (Figure 5A).ighUCP1mRNA expression (n = 11,UCP1CT values between 19 and 27; t test)
1 CT values between 27 and 37; yellow), and high-UCP1 BAT (n = 11; orange;
**p < 0.01; ***p < 0.001.
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Figure 3. CRLS1 Enhances Inducible Uncoupling in Thermogenic Fat Cells
(A–D) Gene expression and NE-induced respiration from primary brown (A) and subcutaneous (B) adipocytes electroporated with either empty pcDNA vector or
vector expressing Crls1 (one-way ANOVA). Oxygen consumption profiles from control and Crls1 siRNA-treated (C) primary brown and (D) subcutaneous
adipocytes following addition of oligomycin and NE stimulation (repeated measures two-way ANOVA). Quantified levels of basal, ATP synthesis-coupled,
NE-induced uncoupled, and maximal respiration are provided to the right (t tests).
(E and F) (E) Crls1 mRNA levels and cardiolipin (CL) labeling for 6 hr and (F) oxygen consumption profiles of primary brown adipocytes from control Crls1f/f and
Rosa26ERT2-Cre/Crls1f/f mice treated with tamoxifen (TAM). Data are presented as means ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001.
See also Figure S3.To gain insight into the potential mechanism through which
this regulation was occurring, we examined genes that were up-
regulated by loss of CL. The gene most significantly increased in164 Cell Metabolism 28, 159–174, July 3, 2018AdCKO iBAT over controls was Ero1l, an established endo-
plasmic reticulum (ER) stress response gene (Figure 5B). Ero1l
is potently activated by the transcriptional regulator, C/EBP
(legend on next page)
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homologous protein 10 (CHOP-10, also known as DDIT3 or
GADD153) (Marciniak, 2004). Several other genes activated by
CHOP-10 were similarly increased in AdCKO iBAT (Figure 5C).
Interestingly, CHOP-10 not only activates ER stress response
genes but can also directly suppress C/EBP target genes (Oya-
domari and Mori, 2004), including those involved in adipose dif-
ferentiation (Batchvarova et al., 1995). Whether CHOP-10 mod-
ulates thermogenic fat gene expression downstream of CL is
unknown. Strikingly, the reduction of Ucp1 and other nuclear-
encoded mitochondrial genes caused by loss of Crls1 was
completely blocked by Chop-10 knockdown in brown adipo-
cytes (Figure 5D). Thus, we have uncovered a novel role for
adipose mitochondrial CL in modulating nuclear transcription
via the ER stress response factor, CHOP-10.
Thermogenic Fat Cardiolipin Controls Systemic
Metabolic Flexibility and Glucose Homeostasis
Given the profound impact of CL on mitochondrial function,
glucose uptake, and nuclear transcription in thermogenic fat,
we next investigated the role of CL biosynthesis in both brown
adipose and organismal metabolic homeostasis. CL depletion
in iBAT created a pathological metabolite signature underscored
by a shift in acylcarnitines from shorter (%10 carbons) to longer
chain species (>10 carbons) and significant decreases in tricar-
boxylic acid (TCA) intermediates, redox cofactors, uric acid
production, purine nucleotides, and coenzyme A-related metab-
olites (Figures 6A and S6A).
We used indirect calorimetry to evaluate the consequence
of adipose Crls1 deficiency on systemic energy homeostasis.
AdCKOmice exhibited a marked blunting in the daily respiratory
quotient (RQ) biorhythm compared with controls indicating
reduced metabolic flexibility (Figure 6B). Furthermore, AdCKO
mice on chow diet displayed significantly reduced fat accumula-
tion in adipose depots (Figure 6C) and decreased insulin sensi-
tivity (Figures 6D and S6B) compared with controls despite
having no genotypic differences in body weight or composition,
food intake, physical activity, or energy expenditure (Figures
S6C–S6F). AdCKO livers were larger than controls but hepatic
triglyceride concentrations were unchanged (Figure S6G).
When challenged on a 60% high-fat diet (HFD), AdCKO mice
gained significantly less weight and had more lean mass and
less fat mass than controls (Figures 6E and S6H). HFD exacer-
bated the chow-fed AdCKO phenotype in adipose and liver sizes
(Figure 6F), increased fasting blood glucose (Figure S6I), andFigure 4. CRLS1 Is Critically Required for the Adipose Thermogenic P
(A) Crls1 mRNA levels in tissues from control and AdCKO mice (n = 6–7; t tests).
(B) Liquid chromatography-mass spectrometry (LC-MS) based quantification of c
photos of control and AdCKO iBAT (B; inset).
(C) Representative transmission electron microscopy (TEM) images of control an
(D and E) Three-dimensional reconstructions of a (D) control and (E) AdCKO ad
croscopy stacks.
(F) Rectal temperature of control and AdCKO mice subjected to a 22C–4C cold
(G–K) (G) Oxygen consumption, (H) schematic of BAT thermogenesis assessme
anesthetization and 1mg/kg NE subcutaneous administration (n = 6 per group, two
mice before and after 3 weeks of cold adaptation.
(L and M) (L) Quantified mean glucose uptake and (M) representative images of 1
(FDG-PET/CT) from control and AdCKO mice following intraperitoneal administra
***p < 0.001.
See also Figures S4 and S5 and Videos S1, S2, S3, and S4.
166 Cell Metabolism 28, 159–174, July 3, 2018rendered AdCKO mice completely refractory to insulin (Fig-
ure 6G). While the precise mechanism(s) of how adipose CL
depletion has such profound ability to modulate organismal en-
ergy homeostasis is unknown, one potential contribution may
come from signaling factors released from the fat tissue into
circulation. Indeed, AdCKO iBAT displayed significant increases
in the expression of several secreted factors (Figure S6J) that
are documented effectors of systemic metabolism (Villarroya
et al., 2016).
While the AdCKO model demonstrates the importance of ad-
ipose CL in glycemic control, it cannot distinguish the contribu-
tion of thermogenic adipocytes from that of white. Therefore,
we generated inducible brown and beige adipose Crls1 knock-
outs (iBAdCKO) by crossing Crls1f/f mice with animals express-
ing a Cre recombinase and estrogen receptor fusion protein un-
der the control of the Ucp-1 promoter (Rosenwald et al., 2013)
(Figure S6K). Induced Crls1 deletion in iBAT of adult mice led
to distinctly paler brown fat (Figure 6H), decreased nuclear-en-
coded mitochondrial genes in iBAT (Figure S6L), and reduced
iBAT mitochondrial mass (Figures 6I and S6M), consistent with
the results from AdCKO mice. In contrast to AdCKO mice,
iBAdCKO mice showed no changes in expression of mitochon-
drial genes in scWAT (Figure S6N), nor did they exhibit fat loss
in white adipose depots or hepatomegaly (Figure 6J). The differ-
ence in white fat weights in AdCKO but not iBAdCKO mice
highlights the importance of mitochondria for the integrity and
storage capacity of white adipose tissue. Notably, iBAdCKOs
still displayed marked insulin resistance (Figure 6K). Thus, our
results reveal that CL in thermogenic fat mitochondria exerts
profound control over whole-body energy homeostasis indepen-
dent of changes in white adipose tissue.
Adipose CRLS1 Is Positively Linked to Insulin Sensitivity
in Humans and Boosts Fat Cell Respiration
To address the clinical relevance of our findings, we analyzed
genetic associations from several Danish population-based
cohorts for links between CL-related genes and parameters of
metabolic disease. We identified a rare (minor allele frequency
0.05%) synonymous variant in CRLS1 (rs149380663) that is
positively associated with multiple indicators of insulin resis-
tance and negatively associated with measures of insulin sensi-
tivity (Figure 7A). Conversely, no such associations were found
with SNPs for other enzymes involved in the de novo CL synthe-
sis pathway (Table S1). Given the enrichment ofCRLS1 in humanrogram
ardiolipin species from control and AdCKO iBAT (n = 6 per group, t tests) and
d AdCKO mitochondrial structure.
ipocyte generated from dual-beam focused ion beam scanning electron mi-
challenge for 1.5 hr (n = 8 per group; two-way ANOVA).
nt, and (I) interscapular temperature from control and AdCKO mice following
-way ANOVA).Ucp1mRNA in (J) iBAT and (K) scWAT from control and AdCKO
8F-fluorodeoxyglucose positron emission tomography/computed tomography
tion of CL-316,243. Data are presented as means ± SEM. *p < 0.05; **p < 0.01;
Figure 5. Mitochondrial CL Deficiency Suppresses Nuclear-Encoded Genes through the ER Stress Response Factor CHOP-10
(A) Reactome pathways downregulated in AdCKO iBAT compared with control (RNA sequencing [RNA-seq] data; n = 5 per group; housed at 22C; dashed line
indicates adjusted p value <0.05).
(B) Volcano plot of RNA-seq data from AdCKO and control iBAT (n = 5 per group).
(C) mRNA levels of known CHOP-10 targets from RNA-seq data (n = 5 per group).
(D) mRNA levels from brown adipocytes treated with control, Crls1, Chop10, or both Crls1 and Chop10 siRNA. Data are presented as means ± SEM. *p < 0.05;
***p < 0.001.brown fat, it is tempting to speculate that adipose CL biosyn-
thesis is, at least in part, contributing to the observed association
with glycemic control. However, genetic variants will potentially
have an impact on any tissue that expresses CRLS1, thus it is
not currently possible to assign causality of this variant to fat.
Therefore, we directly investigated whether altered CRLS1
levels in human adipose tissue were linked to metabolic disease.
Subcutaneous adipose tissue was analyzed from 171 subjects
with normal glucose tolerance (NGT), impaired glucose toler-
ance (IGT), or type 2 diabetes mellitus (T2DM). We found that
expression of CRLS1mRNA was significantly reduced in subcu-taneous fat from diabetic subjects (Figure 7B). Importantly, this
decrease in CRLS1 in T2DM patients was not attributable to
a general trend in mitochondria-linked gene expression, as
mRNA levels of the canonical mitochondrial marker citrate syn-
thase (CS) were unchanged across disease status (Figure 7C).
We then assessed the relationship between CRLS1 and CS
mRNA levels and several related parameters of glucose meta-
bolism and adiposity. The CRLS1mRNA levels in human scWAT
negatively correlated with HOMA2 measures of insulin resis-
tance and positively correlated with HOMA2 measures of insulin
sensitivity (Figure 7D). Conversely, no such association wasCell Metabolism 28, 159–174, July 3, 2018 167
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found with CS (Figure 7E). However, both CRLS1 and CS nega-
tively correlated with waist/hip ratio (Figures 7F and 7H). These
findings suggest that CRLS1 has a unique influence on systemic
glycemic control.
To determine if the positive link between adipose CRLS1 and
metabolic homeostasis in humans could be partly attributable to
cell-autonomous effects, we performed CRLS1 gain-of-function
studies in humanwhite adipocytes isolated from the neck region.
We used a CRISPRa synergistic activation mediator (SAM) sys-
tem (Lundh et al., 2017) to drive expression of the endogenous
CRLS1 gene (Figure 7H). As in our mouse brown adipocytes,
increased CRLS1 expression in human white adipocytes stimu-
lated UCP1 expression and increased inducible uncoupled
respiration (Figures 7I and S6O). Taken together, these data
show that CRLS1 is significantly linked to insulin sensitivity in
humans and can be targeted to stimulate energy expenditure
in adipocytes.
DISCUSSION
Products of lipid metabolism, including fuels, signaling mole-
cules, and cellular structural components, are broadly required
for activation of thermogenic adipocytes (Cannon and Neder-
gaard, 2004; Lynes et al., 2017; Ouellet et al., 2012; Simcox
et al., 2017), yet little is known about which specific lipid path-
ways are most influential in shaping thermogenic fat function.
Previous snapshots of cold exposed brown fat have indicated
the importance of TAG and phospholipid metabolism (Forner
et al., 2009; Marcher et al., 2015). In the present study, we gener-
ated the first global proteomic and lipidomic landscapes of
brown fat throughout the dynamic adaptation to cold tempera-
ture. Combined with beige fat lipidomics, we were able to
pinpoint the mitochondrial inner membrane phospholipid, CL,
and its synthase, CRLS1, as primary mediators in the activation
and recruitment of thermogenic fat.
We found Crls1 to be overwhelmingly enriched in iBAT
compared with other major metabolic tissues. Loss of Crls1
and CL abolished the thermogenic capacity of adipose tissue
through a dramatic disruption of mitochondrial bioenergetics.
In addition to ubiquitous roles in the formation and maintenance
of mitochondrial function, CL is likely to have brown and beige
fat-specific functions in thermogenesis. One such function could
be direct activation of the thermogenic effector, UCP1. Previous
in vitro studies have demonstrated that CL binds tightly to UCP1,
aids in its proper folding (Hoang et al., 2013; Lee et al., 2015), and
decreases its binding affinity for inhibitory purine nucleotides
(Klingenberg, 2009). Moreover, one of the predicted CL bindingFigure 6. CL Depletion in Fat Promotes Whole-Body Metabolic Inflexib
(A) Heatmap of significantly changed metabolites from targeted LC-MS metabolo
(B) Daily RQ for control and AdCKO mice housed in metabolic cages (n = 6 per g
(C and D) (C) Tissue weights (n = 7–10 per group; t tests), and (D) insulin sensitivity
x-y plots and t test for area under the curve [AUC]).
(E–G) (E) Weight gain, (F) tissue weights, and (G) insulin sensitivity of control and A
for AUC).
(H) Photos of control and iBAdCKO iBAT tissues.
(I–K) (I) Mitochondrial content (measured by citrate synthase [CS] activity; n = 8
sensitivity of control and iBAdCKO mice fed chow diet (n = 7 per group; two-way
*p < 0.05; **p < 0.01; ***p < 0.001.
See also Figure S6.sites on UCP1 is in close proximity to a cysteine residue whose
free radical-induced sulfenylation promotes thermogenic capac-
ity (Chouchani et al., 2016). In addition, CL physically interacts
with creatine kinase (Paradies et al., 2014), a key enzyme that
drives a heat-producing futile cycle in beige fat (Kazak et al.,
2015). Therefore, it is likely that CRLS1 and CL synthesis are
central to both UCP1-dependent (Chouchani et al., 2016; Golo-
zoubova et al., 2001; Shabalina et al., 2013) and -independent
(Kazak et al., 2015) thermogenic mechanisms.
Our studies unexpectedly led to the discovery of a novel role of
CL in mitochondria-to-nucleus retrograde communication. Loss
of CL synthesis caused global, cell-autonomous changes in
nuclear transcription that included a repression of Ucp1 and
mitochondrial gene programs. This transcriptional control was
mediated through the ER stress response factor CHOP-10.
Intriguingly, Crls1 gain-of-function increased Ucp1 expression
and inducible uncoupled respiratory capacity in both mouse
and human adipocytes. The mechanism underlying this positive
feedforward activation of the thermogenic program by CL syn-
thesis in adipose tissue is not clear. Nevertheless, the dynamic
nature of CRLS1 mitonuclear signaling suggests that CL may
serve as a rheostat to convey the mitochondrial bioenergetic
potential to the nucleus in order to coordinate maximal thermo-
genic capacity.
The activity of thermogenic adipose tissue is strongly corre-
lated with parameters of metabolic health (Lee et al., 2013) and
positively modulates glucose homeostasis in mice (Stanford
et al., 2013) and humans (Chondronikola et al., 2014), yet until
recently, it was unknown if dysfunction of adipose thermogene-
sis could contribute to insulin resistance. The advent of brown
and beige adipocyte-specific loss-of-function models (Kong
et al., 2014; Rosenwald et al., 2013) has prompted conceptual
leaps in the understanding of how thermogenic fat cells influence
systemic metabolism. For example, deletion of the transcrip-
tional regulator Irf4 in Ucp1+ adipocytes disrupts the thermo-
genic gene program and exacerbates HFD-induced insulin resis-
tance (Kong et al., 2014). Surprisingly, several studies have
ablated major cellular programs in Ucp1+ adipocytes, including
AKT2 signaling (Sanchez-Gurmaches et al., 2018), ATGL-medi-
ated lipolysis (Schreiber et al., 2017), and mitochondrial fusion/
fission dynamics (Mahdaviani et al., 2017), without reducing
glycemic control. In contrast to these findings, we demonstrate
for the first time that mitochondrial dysfunction in thermogenic
fat is sufficient to cause whole-body insulin resistance.
Disruption of CL species is implicated in the pathology of
several diseases, notably Barth syndrome, cardiomyopathy,
metabolic disease, and cancer (Houtkooper and Vaz, 2008;ility and Insulin Resistance
mics of iBAT from control and AdCKO mice (n = 6 per group, t tests, p < 0.05).
roup).
of control and AdCKOmice on chow diet (n = 11 per group, two-way ANOVA for
dCKO mice on HFD (n = 11 per group, two-way ANOVA for x-y plots and t test
per group, t tests), (J) tissue weights (n = 8 per group, t tests), and (K) insulin
ANOVA for x-y plots and t test for AUC). Data are presented as means ± SEM.
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Shi, 2010). Our tissue-specific Crls1 knockout models provide
definitive causality between deficient CL synthesis in thermo-
genic fat and diabetic pathogenesis. Our discoveries of a
CRLS1 variant associated with insulin resistance and reduced
CRLS1 levels in fat from diabetic patients indicate that CL
biosynthesis in adipose tissue could contribute to glycemic
balance in humans. Importantly, we found a positive correlation
between adipose CRLS1 levels and clinical markers of insulin
sensitivity and showed that induction of CRLS1 expression in
human adipocytes can increase energy dissipation. These
findings suggest that positive modulation of CLs in fat could
improve glucose homeostasis and promote metabolic fitness.
Taken together, our data support a novel paradigm in which
adipose CL synthesis is a key control point for systemic glucose
regulation.
Limitations of the Study
The use of Adipoq-Cre in a majority of our studies makes it diffi-
cult to dissect specific effects of CLs in white adipose tissue
versus BAT. To address brown fat contributions, we generated
an inducible BAT-specific Crls1 knockout model, iBAdCKO, yet
the specific effect of CL depletion in white adipose remains to
be determined. Another limitation is that, while we have clearly
shown mechanistic data from cells that reduced CL levels sup-
press Ucp1 expression through the ER stress response protein
CHOP-10, we do not know the signaling molecules that trigger
this effect. Our data from human adipose tissue are limited to
mRNA levels and would be strengthened if we could quantify
the levels of CLs within these or similar samples. Finally, a
weakness of our human data is that the CRLS1 SNP we
analyzed is non-coding, and we have not investigated the
effect of this mutation on gene expression or function. We
hope that future work will provide a greater understanding of
how CLs modulate systemic metabolism through adipose tis-
sue mitochondria.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Wild-Type Mice for Cold Exposure Studies and Primary Cell Culture
All animal studies were performed with approved protocols from the The Danish Animal Experiments Inspectorate permit number
2014-15-0201-00181 and the University of Copenhagen project number P14-379 and P16-021. Male wild-type C57Bl/6NRj mice
(Janvier) were used for cold exposure studies and primary preadipocyte cultures. Unless otherwise noted, mice were group housed
on a 12-hour light/dark cycle (lights on at 6:00 and off at 18:00) and given ad libitum access to chow food (Altromin, 1310). For cold
exposure experiments, twelve-sixteen week old mice were individually housed and placed into climate controlled rodent incubators
(Memmert HPP750Life) set to 29C to acclimate to thermoneutrality for two weeks. Cold exposure mice were then moved to an
incubator set to 5C and kept there until dissection.
Genetically-Modified Mouse Lines
FloxedCrls1mice (Crls1f/f) were generated by Genoway (France). Exon 4, which contains part of the CDP-alcohol phosphatidyltrans-
ferase domain, was flanked by loxP sites. Cre-mediated deletion of exon 4 disrupts the enzymatic domain of CRLS1 and results in
out-of-frame splicing and premature stop codons. To achieve adipose specific or tamoxifen inducible deletion, floxed models were
crossed with Adipoq-Cre mice, B6;FVB-Tg(Adipoq-cre)1Evdr/J (Jackson Laboratories Stock No: 008463) (Eguchi et al., 2011) or
Rosa26ERT2, B6.129-Gt(ROSA)26Sortm1(cre/ERT2)Tyj/J (Jackson Laboratories Stock No: 008463). For studies with Adipoq-Cre/
Crls1f/fmice, controls were homozygous floxed without Cre. For primary cell studies using tamoxifen to induce Crls1 knockout using
Rosa26ERT2/Crls1f/f mice, controls were homozygous floxed without Cre treated with tamoxifen. For Crls1 knockout in UCP1-pos-
itive cells, Crls1f/f mice were crossed with the tamoxifen-inducible B6-Tg(Ucp1-cre/ERT2)426Biat mouse line (kindly provided by
Prof. Christian Wolfrum) (Rosenwald et al., 2013). To induce knockout in this model, 2 mg of tamoxifen (Sigma-Aldrich T5648) in
100 ml of corn oil (Sigma-Aldrich C8267) was delivered by oral gavage once per day for 3 consecutive days. Control mice were
Crls1f/f without Ucp1-Cre/ERT2 and were given an identical dosage of tamoxifen.
Human Adipose Samples
Samples of human supraclavicular BAT and subcutaneous adipose tissue samples were from a previously published study (Jes-
persen et al., 2013). Subjects whowere suspected of cancer in the neck areawere included via the outpatient clinic at the Department
of Oto-Rhino-Laryngology Head & Neck Surgery at Rigshospitalet, Copenhagen, prior to elective surgery in the neck area. Control
samples originated from seven age, sex and BMI matched participants in the study ‘‘Estrogen Receptors and Inflammatory Markers
in Adipose Tissue and Muscle. Association between Gender, Adiposity and Insulin Resistance’’ and were obtained from subcutane-
ous adipose tissue during cholecystectomy at the Department of Abdominal Surgery, Hvidovre Hospital. Biopsieswere obtained dur-
ing surgery by an experienced surgeon. Tissue was removed using scalpel and scissor. Immediately after removal samples were
flash frozen in liquid nitrogen before being stored on – 80C until analyses were performed. Due to large variation inUCP1 expression,
supraclavicular samples were divided into a BAT high and a BAT low group based on UCP1 expression, n = 10 and n=9 respectively.
Subcutaneous abdominal adipose tissue samples from individuals with normal glucose tolerance (NGT), impaired glucose toler-
ance (IGT) or type II diabetes similarly originated from a previous study (Pedersen et al., 2012). Biopsies were obtained using a modi-
fied version of the Bergstro¨m needle biopsy procedure. Participants were classified as having NGT, IGT, or type 2 diabetes according
to the definition from the World Health Organization (WHO) on the basis of blood glucose levels while fasting and at 2 h post glucose
load during an oral glucose tolerance test (OGTT). The homeostatic model assessment of insulin resistance 2 (HOMA-IR) index for
insulin resistance and the estimates of insulin sensitivity (HOMA_%S) were calculated from fasting glucose and insulin, as well as
fasting glucose and C-peptide blood concentrations using the HOMA2 Calculator 2.2.3 (Diabetes Trials Unit, University of Oxford,
http://www.dtu.ox.ac.uk/homa). The study protocols were approved by The Scientific-Ethics Committees of the Capital Region
and of Copenhagen and Frederiksberg Municipalities, Denmark, (journal number H-A-2009-020, H-A-2008-081) and the Regional
Committee on Biomedical Research Ethics in Denmark (journal number H-C-2008-101), respectively. All subjects provided written
informed consent prior to participation. The Scientific-Ethics Committees of the Capital Region and of Copenhagen and Frederiks-
berg Municipalities, Denmark approved the study protocols, journal number H-A-2009-020, H-A-2008-081 respectively, and the
studies were performed in accordance with the Helsinki declaration.
Human Adipocyte Isolation, Immortalization and Culture
For CRISPRa CRLS1 gain-of-function in human adipocytes, isolation of primary stromal vascular fraction (SVF) cells from human
neck fat was described previously (Xue et al., 2015). Specifically, subcutaneous and subplatysmal neck fat depots were pooled
to generate hWAT-SVF cells. Freshly resected fat depots were collected, minced and digested using collagenase 1 (2 mg/ml in
PBS with the addition of 3.5% BSA; Worthington Biochemical Corporation, Lakewood, NJ), and the SVF was isolated. SVF cells
were plated and grown in high-glucose Dulbecco’s modified Eagle’s medium (DMEM/H) supplemented with 10% (vol/vol) fetalCell Metabolism 28, 159–174.e1–e11, July 3, 2018 e3
bovine serum (FBS) and 1%penicillin-streptomycin. For adipocyte differentiation, cells were grown to confluence for 6 days (referred
to as ‘day 6’) and then exposed to adipogenic induction mixture in DMEM/H medium containing 0.5 mM isobutylmethylxanthine,
0.1 mM dexamethasone, 0.5 mM human insulin (Sigma Aldrich), 2 nM T3, 30 mM indomethacin, 17 mM pantothenate, 33 mM biotin
and 2% FBS for another 12 days (referred to as ‘day 18’). Induction medium was changed every 3 days until cells were collected.
Primary SVF cells were immortalized with hTERT. Briefly, primary SVF isolated from subjects that had undergone four or five
population doublings were separately infected with a retrovirus containing the plasmid, pBABE-hTERT-Hygro (Addgene no. 1773,
Cambridge, MA), which expresses hTERT driven by a long-terminal-repeat promoter. Phoenix-A cells (ATCC) were transfected
with pBABE-hTERT-Hygro DNA using PolyJet DNA in vitro transfection reagent (SignaGen Laboratories, Rockville, MD). Culture
supernatants containing virus were collected every 24 h after transfection and filtered through a 0.45 mm filter (Fisher Scientific,
Pittsburgh, PA). Primary SVF cells from human white fat at 80% confluence were infected with supernatants in the presence of
4 mg/ml Polybrene every day until cells reached 90% confluence. Cells were then treated with hygromycin (concentrations ranging
from 100 mg/ml to 400 mg/ml, depending on cell conditions) in DMEM/H medium containing 10% FBS and antibiotics. Once drug
selection was finished, the cells were maintained in culture medium with 50 mg/ml hygromycin for 2 weeks.
Immortalized progenitor cells were plated and grown in DMEM/H medium supplemented with 10% FBS (day 0). For adipocyte
differentiation, cell were grown for 6 d until reaching confluence (day 6), and then treated with the adipogenic induction medium
as described above for 12 d (day 18). We routinely checked for mycoplasma contamination and all the cells used in this study
were free of mycoplasma.
Human Genetic Association of Variants in CL Synthesis and Remodeling Genes
We investigated associations between coding genetic variants in four CL-related genes (CRLS1, PGS1, CDS2, PTPMT1) and meta-
bolic phenotypes in up to 15,840 Danish individuals from five cohorts: Inter99, Health2006, Health2008, Vejle Biobank and type 2
diabetes patients from Steno Diabetes Center. Information on these cohorts has been published previously (Albrechtsen et al.,
2013; Jørgensen et al., 2003; Thuesen et al., 2014). The study was approved by the Regional Ethical Committee of Copenhagen
and is in accordance with the scientific principles of the Helsinki Declaration II. We used genetic variation on the Illumina Exome Bea-
dArray v1.0. Genotypes were called using GenCall applying a custom-made cluster file based on 6,000 samples with high quality
data. From the ExomeBeadChip, quality control of samples and variants was done using PLINK and included exclusion of samples
showing relatedness (first- and second-degree relatives), extreme inbreeding coefficient (F<0.1 or F>0.1), low call rate (<98%) or
mismatch between sex status in phenotype and genotype data. All variants obeyed Hardy Weinberg equilibrium. After QC,
15,840 samples fulfilled quality criteria. We identified 10 variants in three (CRLS1, PGS1, PTPMT1) of these four genes with >10 car-
riers of the alternative allele among all 15,840 samples and these variants were analyzed in relation tometabolic traits related to insulin
resistance. Metabolic traits related to insulin resistance were analyzed. These traits were: body mass index (n=14,684), waist-hip ra-
tio (n=12,380), fasting serum insulin (n=9,072), 2-h serum insulin during an oral glucose tolerance test (n=6,225), together with derived
indices of insulin sensitivity: homeostasis assessment of insulin resistance (HOMA-IR) (n=9,066), Matsuda Insulin sensitivity index
(n=5,744) and BIGTT-insulin sensitivity (BIGTT-SI) (n=5,744). Association analyses were performed by linear regression adjusted
for age, sex and the first four principal components from a principal component analysis. Phenotypes were rank normalized sepa-
rately in each of the cohorts prior to the analysis to obtain a normal distribution.
Mouse Adipocyte Cultures
For gain- and loss-of-function studies with primary mouse adipocytes, iBAT (for brown) or scWAT (for beige-like) was freshly
dissected from 5 week old male wild-type C57Bl/6NRj mice (for electroporation and siRNA studies) or RosaERT2-Cre Crls1f/f (for
tamoxifen-inducible knockout). For preadipocyte isolation, adipose depots from 2 mice was combined, finely minced with scissors,
digested with DMEM containing 0.2% collagenase type 1 (#LS004194, Worthington Biochemical) and 2% bovine serum albumin
(BSA; Sigma Aldrich A7030). Digests were centrifuged, resuspended in DMEM (Sigma Aldrich D5030) with 10% fetal bovine serum
(FBS; Sigma-Aldrich F7524) and penicillin/streptomycin (Lonza DE17-602E) and transferred through a 40 mm nylon strainer onto
6-well plates. Cells were rinsed the following day, and media was changed every 2 days. Upon confluency, cells were differentiated
with DMEM containing a differentiation cocktail of 86 nM insulin, 0.1 mM dexamethasone, 1 mM rosiglitazone, 1 nM T3 and 250 mM
methyl isobutyl xanthine (IBMX). After 2 days, differentiation media was replaced with DMEM containing 10% FBS with 0.5 mg/mL
insulin with (brown) or without 1 nM T3 (beige-like). Media was changed every 2 days. Cells were incubated at 37C with 10%
CO2. Immortalized mouse brown preadipocytes have been previously described (Harms et al., 2014). Cells were grown with
DMEM with 10% fetal bovine serum and penicillin/streptomycin. Upon confluency, cells were differentiated with DMEM containing
a differentiation cocktail of 20 nM insulin, 1 mM dexamethasone, 0.5 mM rosiglitazone, 1 nM T3 and 500 mMmethyl isobutyl xanthine.
After 2 days of differentiation, media was replaced with DMEM with 10% FBS containing 1 nM T3 and 20 nM insulin.
METHOD DETAILS
Proteomics
Twelve-week oldmale C57Bl/6Nmice were acclimated to thermoneutrality (29C) and individually housedwere subject to cold expo-
sure (5C) for 8 hours, 1 day, 3 days, 1 week or 3 weeks iBAT was collected at dissection and snap frozen in liquid nitrogen. Brown
adipose tissues were mechanically lysed with a homogenizer with 2 mL SDS lysis buffer containing 2.0 % SDS w/v, 150 mM NaCl,e4 Cell Metabolism 28, 159–174.e1–e11, July 3, 2018
PhosStop (Roche, Madison, WI) phosphatase inhibitors, EDTA free protease inhibitor cocktail (Promega, Madison, WI) and 50 mM
HEPES, pH 8.5. Lysates were reducedwith 5mMDTT and cysteine residues were alkylated at room temperature with iodoacetamide
(14 mM) in the dark as previously described (Huttlin et al., 2010). Protein content was purified by methanol/chloroform extraction.
Protein disks were resuspended in 8 M Urea containing 50 mM HEPES (pH 8.5) and concentrations were measured by BCA assay
prior to protease digestion. 1mg of protein lysates were diluted to 4M urea and digested with LysC (Wako, Japan) in a 1/100 enzyme/
protein ratio overnight. Protein extracts were diluted further to a 1.0 M urea concentration and trypsin (Promega, Madison, WI)
was added to a final 1/200 enzyme/protein ratio for 6 hours at 37C. Digests were acidified with 20 uL of 20% formic acid (FA) to
a pH  2 and subjected to C18 solid-phase extraction (SPE) (Sep-Pak, Waters, Milford, MA).
Isobaric labeling of peptides was performed using 10-plex tandem-mass tag (TMT) reagents (Thermo Fisher Scientific, Rockford,
IL). TMT reagents (0.8 mg) were dissolved in 42ml dry acetonitrile (ACN) and 10 ml was added to 100 mg of peptides dissolved in 100 ml
of 200mMEPPS, pH 8.0. After 1hr (RT), the reaction was quenched by adding 4 ml of 5% hydroxylamine. Labeled peptides were com-
bined, acidified with FA (pH 2) and diluted to a final 5% ACN concentration prior to C18 SPE on Sep-Pak cartridges (50 mg).
Basic pH reversed-phase HPLC (bpHrp) TMT labeled peptides were subjected to orthogonal bpHrp fractionation. Labeled
peptides were solubilized in buffer A (5% ACN 10 mM ammonium bicarbonate, pH 8.0) and separated by an Agilent 300 Extend
C18 column (5 mm particles, 4.6 mm ID and 220 mm in length). Using an Agilent 1100 binary pump equipped with a degasser and
a photodiode array (PDA) detector (Thermo Scientific, San Jose, CA), a 50 min linear gradient from 12% to 45% acetonitrile in
10mM ammonium bicarbonate pH 8 (flow rate of 0.8 mL/min) separated the peptide mixtures into a total of 96 fractions. 96 Fractions
were consolidation into 12 samples, acidified with 10 ml of 20% formic acid and vacuum dried. Each sample was re-dissolved in 5%
formic acid, desalted via StageTips, dried via vacuum centrifugation, and reconstituted for LC-MS/MS analysis.
Mass spectrometry analysis: All bpHrp fractions were subjected to LC-MS/MS analyses onto a LTQ Orbitrap Velos Fusion
(Thermo Scientific San Jose´, CA) instrument equipped with a Famos autosampler (LC Packings, Sunnyvale, CA) and an Agilent
1100 binary HPLC pump (Agilent Technologies, Santa Clara, CA). Peptides were separated onto a 100 mm I.D. microcapillary col-
umn packed first with approximately 1 cm of Magic C4 resin (5mm, 100 A˚, Michrom Bioresources, Auburn, CA) followed by 25 cm
of Maccel C18AQ resin (1.8 mm, 200 A˚, Nest Group, Southborough, MA). Peptides were separated by applying a gradient from 5 to
35% ACN in 0.5% FA over 180 min at 200 nl/min. Electrospray ionization implemented through applying a voltage of 1.86 kV using
an inert gold electrode via a PEEK junction at the end of the microcapillary column. The LTQ Orbitrap Velos Fusion was operated in
data-dependent manner for the MS methods. The MS survey scan was performed in the Orbitrap in the range of 400-1300 m/z at a
resolution of 3x104, followed by the selection of the ten most intense ions (TOP 10) for CID-MS2 fragmentation in the ion trap using
a precursor isolation width window of 2 m/z, AGC setting of 2000, and a maximum ion accumulation of 150 ms. Normalized collision
energy was set to 35% and an activation time of 20ms. Ions within a 10 ppm m/z window around ions selected for MS2 were
excluded from further selection for fragmentation for 120s. Directly following each MS2 event, 6-10 of most intense fragment
ion in an m/z range between 110-160% of the precursor m/z was selected for HCD-MS3 (McAlister et al., 2012; Ting et al.,
2011). The fragment ion isolation width was set to 4 m/z, AGC was set to 20,000, the maximum ion time was 250ms, normalized
collision energy was set to 60% and an activation time of 50ms for each MS3 scan. For all MS3 scans, Orbitrap resolving power was
set to 30,000 (@ 400 m/z).
Mass spectrometry analysis: Data processing. A compilation of in-house software was used to convert mass spectrometric data
(Raw file) to a mzXML format, as well as to correct monoisotopic m/z measurements and erroneous peptide charge state assign-
ments. Assignment of MS/MS spectra was performed using the Sequest algorithm by searching the data against a protein sequence
database including all entries the Mouse Uniprot database (download date June, 2014) containing known contaminants such as
human keratins and its reverse decoy components (Elias and Gygi, 2007). Sequest searches were performed using a 20 ppm pre-
cursor ion tolerance and requiring each peptides N-/C- termini to have trypsin protease specificity, while allowing up to three missed
cleavages. TMT tags on peptide N termini/lysine residues (+229.162932 Da) and carbamidomethylation of cysteine residues
(+57.02146 Da) were set as static modifications while methionine oxidation (+15.99492 Da) was set as variable modification.
A MS2 spectra assignment false discovery rate (FDR) of less than 1% was achieved by applying the target-decoy database search
strategy (Elias and Gygi, 2007). Filtering was performed using an in-house linear discrimination analysis algorithm to create one com-
bined filter parameter from the following peptide ion andMS2 spectrametrics: Sequest parameters XCorr andDCn, peptide ionmass
accuracy and charge state, peptide length andmis-cleavages. Linear discrimination scores were used to assign probabilities to each
MS2 spectrum for being assigned correctly and these probabilities were further used to filter the dataset to a 1% protein-level false
discovery rate (Huttlin et al., 2010).
TMT reporter ion and quantitative data analysis. For quantification, a 0.003 m/z window centered on the theoretical m/z value of
each ten reporter ions and the closest signal intensity from the theoretical m/z value was recorded. Reporter ion intensities were
further de-normalized based on their ion accumulation time for each MS3 spectrum and adjusted based on the overlap of isotopic
envelopes of all reporter ions (manufacturer specifications). Total signal to noise values for all peptides were summed for each TMT
channel, and all values were adjusted to account for variance in sample handling. For each peptide, a total minimum signal to noise
value of 200 was required (McAlister et al., 2012; Ting et al., 2011).
Pathway Enrichment Analysis (Proteomics)
For pathway analysis of cold exposure iBAT proteomics, proteins that were upregulated more than 1.5 fold compared to thermoneu-
trality (29C) by t test (p < 0.05) were submitted to Enrichr for analysis (Kuleshov et al., 2016). Reactome pathways from Enrichr wereCell Metabolism 28, 159–174.e1–e11, July 3, 2018 e5
presented in bubble chart format to show temporal changes. The Enrichr adjusted p value was used to determine significance. Signif-
icantly enriched Reactome pathways were manually selected.
Lipidomics
For targeted, quantitative lipidomics of cold exposed adipose tissue, mouse iBAT and scWAT of approximately 20 mg was added to
600 mL of 10 times diluted PBS in a 2mL tube from the Precelleys Lysing kit (KT03961-1-001.2). The samples were homogenized for
1 min (3X20 seconds with 10 seconds interval) at 4C by using Precelleys Evolution homogenizer (Bertin Corp, MD). An aliquot of
25 mL was pipetted to determine the protein content (BCA protein assay kit, Thermo Scientific, Rockford, IL). The rest of homogenate
was accurately transferred into a disposable glass culture test tube, and a mixture of lipid internal standards was added prior to lipid
extraction for quantification of all reported lipid species. Lipid extraction was performed by using a modified Bligh and Dyer proced-
ure as described previously (Wang and Han, 2014). Each lipid extract was resuspended into a volume of 200 mL of chloroform/meth-
anol (1:1, v/v) per mg of protein and flushed with nitrogen, capped, and stored at20C for lipid analysis. For ESI direct infusion anal-
ysis, lipid extract was further diluted to a final concentration of500 fmol/mL, and themass spectrometric analysis was performed on
a QqQmass spectrometer (Thermo TSQ QUANTIVA, San Jose, CA) and Orbitrap mass spectrometer (Thermo LTQ Velos, San Jose,
CA) equipped with an automated nanospray device (TriVersa NanoMate, Advion Bioscience Ltd., Ithaca, NY). Lipidomics data was
corrected for protein content in each sample and is presented as absolute quantities within each lipid class in supplemental materials.
Lipid internal standards are listed below (standards were purchased from Avanti Polar Lipids, except as noted):
1,2-Dimyristoleoyl-sn-glycero-3-phosphocholine (di14:1 PC)
1,2-Dipalmitoleoyl-sn-glycero-3-phosphoethanolamine (di16:1 PE)
1,2-Dipentadecanoyl-sn-glycero-3-phosphoglycerol (sodium salt) (di15:0 PG)
1,2-Dimyristoyl-sn-glycero-3-phospho-L-serine (sodium salt) (di14:0 PS)
1,2-Dimyristoyl-sn-glycero-3-phosphate (sodium salt) (di14:0 PA)
1,1’,2,2’-Tetramyristoyl cardiolipin (T14:0 CL)
7,7,8,8-d4-Palmitic acid (d4-16:0 NEFA) (Cambridge Isotope Laboratories)
N-Lauroryl sphingomyelin (N12:0 SM)
N-Heptadecanoyl ceramide (N17:0 Cer)
1-Heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine (17:0 lysoPC)
1,2,3,4-13C4-Palmitoyl-L-carnitine hydrochloride (13C4-16:0 CN) (Sigma-Aldrich)
Triheptadecenoin (T17:1 TAG) (Nu Chek)
1,3- Dipentadecanoin (di15:0 DAG) (Nu Chek)
Monoheptadecenoin (17:1 MAG) (Nu Chek)
Tissue Cardiolipin Profiling by LC/MS
For cardiolipin profiling of adipose tissue, frozen tissue samples from 12 week old female mice were extracted in chloroform:metha-
nol (2:1). Extraction volumes were adjusted according to wet tissue weight (20 mg tissue/400 ml extraction solvent) and internal stan-
dard 400 pmol cardiolipin C14 was added. Samples were sonicated, vortexed thoroughly and centrifuged (2,400 g, 2 min) before
supernatants were transferred to new eppendorf tubes and washed with 0.2 volumes of water by thorough vortexing. Finally, the
samples were centrifuged (400 g, 2 min) whereafter the lower organic phases were transferred to new tubes prior to lyophilization.
Samples were resuspended in 30 ml of solvent A (5:1:4 isopropanol/ methanol/water with 5 mM ammonium acetate and 0.1%
acetic acid) before injection of 5 ml on an Agilent 1290 Infinity HPLC system equipped with an Eclipse Plus C18 RRHD column
(2.1 x 50 mm, 1.8 mm) with a 50 mm guard-column, both kept at 45C. The chromatographic gradient was run at flow rate of
350 ml/min and the following solvent composition of solvent A and B (99:1 isopropanol/water with 5 mM ammonium acetate
and 0.1% acetic acid): 100% A from 0-3 min, 100-80% from 3-5 min, 80-70% from 5-25 min, 70-5% from 25-35 min, 5-5% from
35-36 min and 5-100% from 36-38 min before equilibration for 2 min with the initial conditions. Samples were analyzed with the
MS operation in negative mode. All samples were run in randomized order.
The LC flow was coupled to an Agilent 6530 quadrupole time of flight (Q-TOF) mass spectrometer scanning from 70-1700 m/z
with same settings as above. A library of the different cardiolipin species with retention times (RT) was constructed using Agilent
MassHunter PCDLManager. The identification of each compound was based on the exact mass. Chromatograms for all compounds
were extracted and quantified using Agilent Profinder using a mass tolerance of 20 ppm and a retention time tolerance of 0.1 min.
Lipid Quantification from Cell Lysates by Thin Layer Chromatography
Primary brown adipocytes from Rosa26ERT2-Cre/Crls1f/f mice were treated with tamoxifen (as described above in Tamoxifen-
Induced Crls1 Knockout in Primary Adipocytes) and differentiated. On day 6 of differentiation, cells were incubated in differentiation
media containing a mixture of 30 mM oleate, 15 mM palmitate, and 5 mM linoleate plus 0.5 mCi of [1- 14 C] linoleate for 6 h. Total lipids
were extracted from the cells, and neutral lipids were separated from phospholipids by thin layer chromatography (heptane:isopropyl
ether:acetic acid; 60:40:4; v/v/v). Phospholipids were extracted from the silica gel and different classes were separated using
chloroform:ethanol:water:triethalamine (30:35:7:35; v/v/v/v) (Vaden et al., 2005). Radioactivity in each class was measured using
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Gene Expression Analysis (RT qPCR and RNA-seq)
For gene expression analysis of tissue and cell samples, RNA extraction was completed using TRI reagent (Sigma-Aldrich). cDNA
synthesis was carried out using a High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Expression data was
analyzed with the DDCT method. Gene expression data was normalized to 36b4 (mouse and cell lines) or PPIA (human tissue). All
primers are listed in Table S2.
For generation of RNA-seq libraries, polyadenylated mRNA was isolated from 1 mg of total RNA by incubation with oligo-dT beads
and prepared according to themanufacturer’s instructions (TruSeq 2, Illumina). Samples were sequenced on the Illumina HiSeq 1500
platform. Sequencing reads were mapped to the mouse reference genome (version mm9) using STAR (Dobin et al., 2013). Tag
directories were generated using HOMER (Heinz et al., 2010) and exon reads were counted using iRNA-seq (Madsen et al.,
2015). Normalization and identification of differentially expressed genes was performed using DESeq2 (Love et al., 2014). For calling
differentially expressed genes, a FDR < 0.01 and threshold of minimum 10 reads per kb on average for the given condition
were used. For analysis of RNA-seq pathway enrichment in AdCKO iBAT, the list of genes downregulated by a third or more with
a p value < 1x10-5 were submitted to Enrichr for analysis (Kuleshov et al., 2016). Reactome pathways from Enrichr were manually
selected for presentation. RNA-seq data was deposited in GEO (GEO: GSE110297).
Metabolomics
Frozen tissue samples from 12week old femalemicewas extracted inmethanol:acetonitrile:water (5:3:2) including internal standards
(0.5 mM butyrylcarnitine D3, 0.25 mM hexadecanoyl D3 and 5 mM heavy labeled amino acid mix standard). Extraction volumes were
adjusted according to wet tissue weight (20 mg tissue/200 ml extraction solvent). Samples were sonicated, vortexed thoroughly and
centrifuged (21,100 g at 4C) for 10 min. Subsequently, 50 ml of the supernatants were transferred into new tubes before
lyophilization.
Metabolites were profiled using LC-MS with RP separation. Samples were redissolved in 20 ml 1% formic acid (FA) in water before
injection of 8 ml on a Agilent 1290 Ininity HPLC system (Agilent Technologies, Santa Clara, CA) equipped with an Agilent Zorbax
Eclipse Plus C18 column (2.1 x 150 mm, 1.8 mm) with a 50 mm guard-column, both kept at 40C. The chromatographic gradient
was run at a flow rate of 300 ml/min with the following solvent composition of A (0.1 % FA, water) and B (0.1% FA, acetonitrile):
97% A from 0-5 min, 97-85% A from 5-8 min and 85-60% A from 8-18 min before equilibration for 3 min with the initial conditions.
Samples were analyzed twice with the MS operating in both positive and negative ion mode, respectively.
All samples were run in randomized order and one mastermix sample (equal amounts pooled from all samples) was included for
all setups and run in all-ion fragmentation mode with collision energy of 20 V in order to produce fragments for identification of
the metabolites. The LC flow was coupled to an Agilent 6530 quadrupole time of flight (Q-TOF) mass spectrometer scanning from
70-1050 m/z. Libraries of metabolites with retention time (RT) were constructed using Agilent MassHunter PCDL Manager. The
identification of each compound was based on exact mass, RT of synthetic standards and/or comparison of fragments with the
Metlin MS/MS database (https://metlin.scripps.edu/). Chromatograms for all compounds were extracted and quantified using
Agilent Profinder using a mass tolerance of 20 ppm and a retention time tolerance of 0.1 min.
CRLS1 Immunoblotting (Western)
Tissue samples were homogenized with metal beads using a TissueLyser (Quigen) with 1.5 minutes of lysis at a frequency of 20s-1
in 1x RIPA buffer (Millipore) buffer supplemented with Pierce Protease and Phosphatase Inhibitor Mini Tablets (Thermo Scientific).
Samples were prepared with sample buffer (NuPage) and DTT, boiled and analyzed. Proteins were run on 3-8% SDS-PAGE gels
(NuPage) and transferred to a PVDFmembrane using a semi-dry blotting technique. Custom rabbit polyclonal anti-CRLS1 antibodies
were ordered fromGenscript (PolyExpress Gold Package; SC1649). Antibodies were separately produced against three CRLS1 pep-
tide antigens (RPPGARLGRGGSRRC, CSGAGKAAPEPAAGG and SARWVPASAASSYEC). Amersham ECL Rabbit IgG, HRP-linked
whole Ab (from donkey) was used as the secondary antibody (GE Healthcare Life Sciences NA934).
Gain-of-Function in Primary Mouse Adipocytes
A mouse Crls1 (NM_001024385) cDNA ORF clone in pcDNA3.1+/C-(K)DYK vector was synthesized by Genscript (OMu17939). One
million primary brown or beige-like adipocytes were electroporated on differentiation day 3with sterile plasmid using aNucleofector II
device with Cell Line Nucleofector Kit L (Lonza VACA-1005) and protocol A-033. Electroporated cells were plated onto either a
96-well plate for gene expression analysis (45k cells/well) or a 96-well Seahorse plate for respirometry analysis (30k cells/well). Cells
were harvested or assayed four days after electroporation.
Gain-of-Function in Human Adipocytes via CRISPRa SAM
Lentivirus expressing dCasp-VP64 and MS2-P65-HSF1 were generated in HEK-293 cells by co-transfecting with psPAX.2 and
psMD2.g plasmids using Superfect transfection reagent (Qiagen). Virus-containing supernatant was harvested 72 hours post trans-
fection and concentrated using Lenti-X concentrator (Clontech). Immortalized human white adipose progenitor cells derived from
human neck fat (see Human Adipocyte Isolation, Immortalization and Culture above) were transduced with virus and 72 hours later
treated with Blasticidin (final concentration of 5 ug/ml) and Hygromycin (final concentration of 25ug/ml). Expression of dCasp-VP64
and MS2-P65-HSF1 were confirmed by qPCR. The CRLS1 sgRNA was designed to target the CRLS1 promoter at the -101 position
upstream from the transcription start site with the following sequence: 5’-CATCAGGCTCAGTGGGTTTT-3’. The sgRNA was clonedCell Metabolism 28, 159–174.e1–e11, July 3, 2018 e7
into the gRNA lentiviral backbone. Lentivirus production, up-concentration and human progenitor transduction were carried out as
described for the other lentiviral constructs. An empty vector (EV) lentiviral backbone-expressing cell line was established to control
for lentiviral infection and drug selection. The sgRNA was transduced into cells stably expressing the core components of the
CRISPRa-SAM system: dCAS9-VP64 and MS2-P65-HSF1 to drive expression of the CRLS1 gene by activating the endogenous
promoter. Selection of sgRNA-expressing cells was done using Zeocin (final concentration of 50 mg/ml). Zeocin was kept in media
during passaging of the cell lines. Confirmation of CRLS1 overexpression (OE) was done in progenitor cells using qPCR. For oxygen
consumption rate experiments, CRLS1 OE and EV cells were differentiated as previously described (Xue et al., 2015).
Loss-of-Function in Mouse Adipocytes with siRNA
At approximately 80% confluency, 160k preadipocytes were reverse transfected onto 12-well plates containing 50 pmoles/well of
siRNA targeting Crls1 (Sigma, SASI_Mm01_00094096) or control siRNA (Sigma, SIC001) using RNAiMAX (Thermo Scientific,
13778100). After reaching confluency, cells were differentiated as described above. On day 3 of differentiation, cells were again
reverse transfected onto either a 96-well plate for gene expression analysis (60k cells/well; 10 pmoles of siRNA) or a 96-well Seahorse
plate for respirometry analysis (30k cells/well; 5 pmoles of siRNA). Cells were harvested or assayed on differentiation day 7. For
experiments with both Crls1 and Chop10 (Ddit3, Sigma, SASI_Mm01_00085431) knockdown, cells were treated with siRNA against
Crls1 as described above, and treated with Chop10 siRNA alone or with Crls1 siRNA on day 3.
Tamoxifen-Induced Crls1 Knockout in Primary Adipocytes
Primary preadipocytes were isolated as described in Primary Mouse Adipocyte Cultures above. Three days after seeding, primary
preadipocytes were approximately 50% confluent and treated with 1 mM 4-hydroxytamoxifen (Sigma, H6278). This treatment was
repeated 24 hours later. Once cells were confluent, they were differentiated as detailed above. Cells were replated onto either a
96-well plate for gene expression analysis (60k cells/well) or a 96-well Seahorse plate for respirometry analysis (30k cells/well). Cells
were harvested or assayed on differentiation day 7.
Mitochondrial Isolation
Mitochondria were isolated by differential centrifugation. Freshly dissected interscapular and sub-scapular iBAT was minced with
scissors in ice cold isolation buffer (IB, 250 mM sucrose in water). Minced tissue was homogenized in 20 ml of IB using a Potter-
Elvehjem type grinder at 500 rpm for 2 min (Velp Scientific DLS). The homogenate was filtered with a cotton cloth and centrifuged
at 10,000 x g for 10 min at 4C. The supernatant was discarded, fat on the tube wall was carefully removed with paper tissue,
and the pellet was resuspended in 2 ml of IB. The suspension was centrifuged again at 800 x g for 10 min at 4C. The supernatant
was transferred to a new tube and centrifuged again at 10,000 x g for 10 min at 4C. The final pellet was frozen at -80C for storage.
Cellular and Mitochondrial Bioenergetics
Primary mouse adipocytes were seeded onto 96-well Seahorse plates on day 2 of differentiation at 20,000 cells per well. On day 7 of
differentiation, cells were rinsed once and media was replaced with 165 ml basal DMEM (Sigma Aldrich D5030) containing 25 mM
glucose, 1 mM sodium pyruvate and 0.5% BSA (Sigma Aldrich A7030). After 1 hour in a non-CO2 incubator at 37
C, plates were in-
serted into a Seahorse XF96 Analyzer. After 3 basal measurements, oligomycin was injected for a final concentration of 1mM to inhibit
ATP synthesis. Next, NE was injected in order to measure adrenergic-induced uncoupled respiration (1 mM for brown adipocytes,
5 mM for beige-like adipocytes). After NE-induced uncoupled respiration was determined, FCCP was injected (final concentration
1 mM) to determine maximal respiratory capacity. Finally, a mixture of rotenone and antimycin was injected to inhibit all mitochondrial
respiration (1 mM each). NE-induced uncoupled respiration curves were calculated by subtracting the oligomycin-dependent OCR
from the OCR values after NE treatment. Cumulative NE-induced uncoupled respiration was calculated as the area under curve.
Metabolic parameters for basal mitochondrial, coupled, NE-induced uncoupled and maximum respiration were calculated relative
to baseline after subtracting non-mitochondrial OCR values (OCR after rotenone and antimycin). Immortal mouse brown adipocytes
were assessed similarly. Bioenergetics of immortal human adipocytes was assessed similarly, except preadipocytes were seeded
directly onto 96-well Seahorse plates and differentiated in-well without rosiglitazone, no BSA was used in the assay media and
adrenergic-induced uncoupled respiration was determined by treatment with 10 mM forskolin instead of NE. For mitochondrial
bioenergetics, mitochondria pellets were resuspended in assay buffer (125 mM sucrose, 20 mM K+-Tes (pH 7.2), 2 mM MgCl2,
1 mMEDTA, 4 mMKH2PO4, and 0.1% fatty-acid-free BSA), and then 2 mg of isolatedmitochondria (as measured by protein content)
was added to each well of a 96-well Seahorse plate. The plate was spun at 2,000 x g for 20 minutes at 4C. After 3 basal readings,
5 mM glycerol-3-phosphate (G3P) was injected to each well, followed by 3 measurements and then 3 mM guanosine diphosphate
(GDP) was added to inhibit UCP1.
Quantification of Mitochondrial Mass (Mitochondrial DNA)
DNA was isolated from adipose tissue using a Gene Elute Mammalian DNA Miniprep Kit (Sigma #G1N70). The ratio of mitochondrial
DNA (mtDNA) to genomic DNA was determined by performing qPCR. Four individual primer sets were used for mitochondrial DNA
that target the mitochondrial genes Nd1, Nd2, Co2 and Cytb (Table S2). Two pairs of primers were used to amplify nuclear DNA
from within the Ucp1 and Pparg loci (Table S2). All primer pairs were run in individual reactions. The mtDNA/nucDNA was calculated
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averaging the ratio obtained from each primer pair. Expression data was analyzed with the DDCT method. All primers are listed in
Table S2.
Quantification of Mitochondrial Mass (Citrate Synthase Activity)
Previously frozen in liquid nitrogen brown adipose tissue (5-10 mg) was homogenized in 500 ml lysis buffer (containing Glycerol 10%,
IGEPAL 1%, NaCl 150 mM , HEPES 50 mM, b-glycerophosphate 20 mM, NaF 10 mM, EDTA 1 mM, EGTA 1 mM, Na-Butyrate 1 mM,
Na-pyrophosphate 20 mM, Na3VO4 2 mM, Thiamet G 4 mM, Nicotinamide 5 mM, 1x cOmplete Mini Roche protease inhibitor cocktail
using QIAGEN TissueLyser II bead homogenizer. Tissue homogenates were rotated end-over-end at 4C for 1 hour, followed by
centrifugation at 16,000 g for 20 minutes at 4C and supernatants were used for the following measurements. Citrate synthase
activity was measured spectrometrically (CLARIOstar microplate reader, BMG LABTECH) in diluted tissue extracts (5-20 times
serial dilutions in 0.1 M Tris-HCl pH 8.1) at 37C in a solution containing 500 mM oxaloacetate, 100 mMDTNB (5,5-dithio-bis-(2-nitro-
benzoic acid), 400 mM Acetyl-CoA, 0.1 M Tris-HCl (pH 8.1) based on the absorption at 412 nm by the product thionitrobenzoic acid
(TNB). Citrate synthase activity was calculated using Equation 1 and expressed as nanomoles of substrate per minute permicrogram
of protein. Protein concentration wasmeasured in the diluted tissue extracts using Precise BCAProtein Assay Kit (Thermo Scientific).
citrate synthase activity =
DA412=min,VðmLÞ
ε
mM,LðcmÞ,total protein ðgÞ (Equation 1)
ε
mM = 13:6mM1 cm1 (the extinction coefficient of TNB at 412 nm), L = 0.535 cm
BN-PAGE and Native Immunoblotting of Mitochondrial Complexes and Supercomplexes
Analysis of mitochondrial complexes and supercomplexes was performed similarly as previously described (Jha et al., 2016). Frozen
mitochondrial isolates were removed from -80C storage and resuspended in either 250 ml (for control), or 100 ml (for AdCKO) of ice
cold IB. Protein content was measured with a micro BCA Protein Assay Kit (Thermo Scientific). Fifty mg of mitochondrial protein was
aliquoted into 1.5 ml tubes and centrifuged at 7,000 x g for 10 min at 4C. The supernatant was discarded and the pellet was either
used immediately or stored at -80C for BN-PAGE. Fifty mg of mitochondrial protein was resuspended in 20 ml of sample buffer cock-
tail, containing 5 ml of 4x NativePAGE sample buffer, 8 ml of 5% digitonin and 7 ml of water. After solubilization by gently pipetting up
and down, samples were incubated for 20 min on ice, then centrifuged at 20,000 x g for 10 min at 4C and supernatants were trans-
ferred to a new tube. Next, 2 ml of G-250 sample additive was added to each sample and they were loaded into a NativePAGE 3-12%
gradient gel. Fifteen ml of Native Mark Unstained Protein Standard (Invitrogen LC0725) was also loaded into the gel. The outer cham-
ber of the running apparatus was filled with 1x Native PAGE running buffer, while the inner chamber of the gel apparatus was filled
with 1x Native PAGE running buffer that contained 0.02% Coomassie Brilliant Blue G-250 (weight/vol). After 30 min at 150 V, the
buffer in the inner chamber was replaced with Native PAGE running buffer containing 0.002% Coomassie Brilliant Blue G-250
(weight/vol). The gel was then run an additional 60 min at 250 V. The gel was then washed with water and imaged. Next, the gel
was incubated in 1x NuPAGE Transfer Buffer for 15 minutes with shaking. The proteins were transferred to a PVDF membrane using
a Power Blotter (Thermo Scientific) set to 25 volts and 1 amp, and run for 60minutes. Following transfer, themembrane was placed in
8% acetic acid for 5 min with shaking and air-dried. For immunoblotting, the membrane was incubated in methanol 3 times for 5 min
with shaking. Next, it was incubated in blocking solution (Western Breeze Chromogenic Immunodetection System, Novex #WB7103)
for 30 min, then washed 2 times with water for 5 min and incubated with primary antibody solution for 90 minutes. Primary antibody
solution consisted of 2 ml of Blocker/Diluent part A, 1 ml of Blocker/Diluent part B (Western Breeze Chromogenic Immunodetection
System), 7 ml water, 10 ml of anti-OxPhos antibody cocktail (Life technologies, cat. no. 457999), and 5 ml of anti-MTCO1 antibody
(Abcam, cat. no. ab14705). The membrane was then washed with 1x antibody wash solution 2 times 5 min (Western Breeze Chro-
mogenic Immunodetection System), followed by 2 times 5 min washes in water. The membrane was then incubated with secondary
antibody solution (Western Breeze Chromogenic Immunodetection System) for 45 minutes with gentle shaking. The membrane was
then washed with 1x antibody wash solution 2 times 5 min (Western Breeze Chromogenic Immunodetection System), followed by
2 times 5 min washes in water. Finally, the membrane was incubated with chromogenic substrate (Western Breeze Chromogenic
Immunodetection System) until bands were clear and washed twice with water before being air-dried, scanned and bands quantified
using a ChemiDoc XRS+ and Image Lab 6.0 software (Bio-Rad). Protein band quantities were normalized to total Coomassie stained
volume per lane.
Quantification of Intracellular Triglycerides
In order to determine tissue triglyceride content, lipids were extracted from 50-200 mg of tissue by overnight incubation at 55C in
ethanolic KOH (66.6% ethanol with 33.3% 30% KOH). Samples were brought to a volume of 1200 ml with 50% ethanol then spun for
5 minutes at maximum speed in a microcentrifuge. After mixing 100 ml of supernatant with 100 ml of 0.5 MMgCl2, samples were kept
on ice for 10 minutes. They were then centrifuged for 5 minutes at maximum speed in a microcentrifuge and supernatant was moved
to a new tube. Glycerol standards were prepared ranging from 1,000 mg/dl down to 1 mg/dl. In a standard 96-well plate, 3 ml of
sample or standard was mixed with 300 ml of Infinity Triglyceride Liquid Stable Reagent (#TR22421, Thermo Fisher Scientific) and
incubated at 37C for 10 minutes before reading. The unknown triolein equivalents (TE) were interpolated from the standard
curve using a least squares (ordinary) fit line calculated with Prism Graphpad software. The total liver triglycerides per sample
was calculated in mg/g tissue by TE*2*0.012/(tissue weight in grams).Cell Metabolism 28, 159–174.e1–e11, July 3, 2018 e9
Indirect Calorimetry
Indirect calorimetry was performed using Home Cage System Phenomaster (TSE Systems). Briefly, animals were acclimated in
training cages for 3-5 days prior to the measurement and were allowed 24 hours to acclimate to the TSE cabinets. Gas exchanges
and food intake were recorded every 5 minutes. Temperature and activity monitoring was conducted using implanted E-Mitter as
described below. All metabolic phenotyping data was analyzed by averaging data from two days of measurements.
Telemetric Temperature and Activity Monitoring
For implantation of telemetric temperature and activity monitoring devices, mice were anesthetized with isofluorane and kept on
heated pads during the procedure. G2 E-Mitter Telemetry System devices (Starr Life Sciences) were surgically implanted subcuta-
neously directly over the interscapular brown adipose depots and sutured into place. ER4000Receivers were placed under the cages
within the TSE cabinets. Temperature and physical activity data was integrated into the Phenomaster software.
Cold Tolerance
Mice were pair-housed at 22C. Food was withdrawn at the commencement of the cold tolerance test as animals were transferred to
new cold acclimated cages containing only bedding material. The cages were then placed into climate controlled rodent incubators
(Memmert HPP750Life) set to 5C. Core body temperature was obtained with a Homeothermic Monitor (Harvard Apparatus) by
gently inserting a thermal probe into the mouse rectum.
Brown Adipose Thermogenic Capacity Procedure
Oxygen consumption and iBAT temperature weremeasured using the Phenomaster system as described above with implanted tele-
metric E-Mitter devices. Male mice at 16 weeks of age were anaesthetized with Pentobarbital (75mg/kg). After oxygen consumption
measurement stabilized again in the system, 1mg/kg of NE was administered subcutaneously and the measurement was continued
until homeostasis was reached. All data was collected every 3 minutes. The climate chamber was kept at 33C during the procedure.
Small Animal FDG PET/CT Imaging
All imaging experiments were performed with an approved protocol from the University of Copenhagen, project number P15-352.
Twenty week old female mice were housed at thermo neutrality the night before imaging and fasted from 7 AM on the day of imaging.
FDGwas administered intraperitoneally between 10AM–12PM. The average radioactive dose was 7.7 MBq (range: 6.5-9.1 MBq). CL
316,243 (1 mg/kg) was administered subcutaneously 15 min prior to FDG administration. Small animal PET/CT (InveonMultimodality
PET/CT scanner; Siemens) was performed 1 hour after FDG administration. Mice were anaesthetized by sevoflurane 30minutes after
tracer injection until the end of the imaging session. Heating was applied in order to maintain normal body temperature. PET data
were acquired in list mode for 300s, and images were reconstructed using a 3-dimensional maximum a posteriori algorithm with
CT-based attenuation correction. CT images were acquired using 360 projections, 65 kV, 500 mA, and 400 ms exposure and recon-
structedwith an isotropic voxel size of 0.210mm. Imageswere analyzed using the Inveon software (Siemens). Quantitative analysis of
the FDG uptake was performed by manually drawing region of interests over the areas containing iBAT based on the CT images. The
FDG uptake was expressed as % injected dose per gram tissue (%ID/g).
Sample Preparation for Electron Microscopy
Ten-week old female mice were anesthetized with isofluorane and perfused with 2% glutaraldehyde. iBAT samples were collected
and fixed with 2% v/v glutaraldehyde in 0.05 M sodium phosphate buffer (pH 7.4) for 48 h followed by three times rinse in 0.15 M
sodium cacodylate buffer (pH 7.4). The specimens were subsequently postfixed in 1% w/v OsO4 and 0.05M potassium ferricyanide
in 0.12 M sodium cacodylate buffer (pH 7.4) for 2 h. Followed by e´n bloc stain in 1% uranyl acetate in distilled water over night,
the specimens were dehydrated in graded series of ethanol, transferred to propylene oxide and embedded in Epon according to
standard procedures.
TEM
Sections, approximately 80 nm thick, were cut with a Leica UC7 microtome and collected on copper grids with Formvar supporting
membranes. Sections were stained with uranyl acetate and lead citrate and subsequently examined with a Philips CM 100 TEM
(Philips, Eindhoven, TheNetherlands), operated at an accelerating voltage of 80 kV. Digital imageswere recordedwith anOSIS Veleta
digital slow scan 2k x 2k CCD camera and the ITEM software package.
FIB/SEM
The Epon embedded specimens were analyzed in Quanta FEG 3D FIB-SEM (FEI, The Netherlands) equipped with a gallium ion
source for milling and a dedicated backscattered electron detector for imaging (vCD). The surface of the block and the trimmed
edge was located with the secondary electron detector in standard SEM mode. Definition of an area of interest was acquired with
the vCD detector at 20 kV accelerating tension. For focused ion beam milling the block was tilted to 52 and the edge of the block
aligned at eucentric height, followed by crossover alignment of both electron and ion beams. The ion beam was used in conjunction
with a gas injection system to deposit a 1 mm layer of platinum above the region of interest to reduce milling artifacts. Next, trenches
approximately 20 mm wide were milled at high beam current on both sides of the region of interest to avoid deposition artifacts. Thee10 Cell Metabolism 28, 159–174.e1–e11, July 3, 2018
G2 Slice and View software (FEI) was used for automatic milling (50 nm) and image recording with automatic refocusing of the
exposed surface.
SEM 3D Image Reconstruction
Two digital image dataset of 562 and 579 images respectively, were recorded from control and AdCKO sample blocks. The images
with the specifications of 2048 x 1768 pixels in 8 bits were assembled and automatically aligned in Amira 6.0.0 – ResolveRT. Voxel
size was 33.5 x 42.3 x 50 nm. From the two image stacks, blood vessels were automatically masked using the LabelField and were
included for 3D reconstruction. 3D models were generated by SurfaceGen and projected by SurfaceView. The lipid droplets and
cellular organelles were visualized using the Volren volume-rendering tool. Finally, the images were captured in high resolution
and the cellular mitochondrial (and other small organelles) were manually false coloured green in Photoshop CC. All images were
post processed in Photoshop CC.
Body Composition Analysis
Mouse fat and lean mass was measured using nuclear magnetic resonance technology with an EchoMRI 4 in 1 Body Composition
Analyzer.
Mouse Metabolic and HFD Studies
For glucose and insulin tolerance tests, mice were fasted for 4 hours starting at 9:00. For glucose challenge, mice were given an
intraperitoneal injection of 2 g/kg body weight glucose. For ITT, mice were injected with 0.75 units/kg body weight (chow-fed) or
1.5 units/kg body weight (HFD-fed) of insulin (Novo Nordisk, Humulin R). Glucose was measured with Contour XT glucometers
(Bayer). GTT and ITT tests were performed 1 week apart. At 16 weeks of age, male mice were kept at 22C and given ad libitum
access to a high fat diet containing 60% kcal from fat, 20% kcal from carbohydrate and 20% kcal from protein (Research Diets,
D12492). Body weights were recorded weekly.
QUANTIFICATION AND STATISTICAL ANALYSIS
Unless otherwise noted, statistical analysis was performed with GraphPad Prism 7.0. Statistical parameters, including the value of n,
are noted in figure legends. Unless otherwise noted, all data are presented as means ± SEM. Statistical analysis of data with more
than 2 groups and without repeated measures was with one-way ANOVA. Repeated measures data with more than 2 groups was
assessed with two-way repeated measures (RM) ANOVA. Data with 2 groups was analyzed by two-tailed Student’s t test. Correction
for multiple comparisons was done using the Holm-Sidak method. Proteomics data was statistically analyzed with Perseus software
(http://www.perseus-framework.org) using ANOVA with a permutation-based false discovery rate with 250 randomizations.
Heatmaps were prepared with Metaboanalyst software (http://www.metaboanalyst.ca/) and GraphPad Prism.
DATA AND SOFTWARE AVAILABILITY
The accession number for the iBAT RNA-seq data is GEO: GSE110297.Cell Metabolism 28, 159–174.e1–e11, July 3, 2018 e11
